Evidence map›Paper›PMID 33644295›Full record

ArticleAlzheimer's & dementia (New York, N. Y.)2021

Cerebral amyloid angiopathy distribution in older people: A cautionary note.

Vafa Alakbarzade, Jonathan Mr French, David R Howlett, Johannes Attems, Paul T Francis, Sarah Stratton, Camilla N Clark, Anthony C Pereira, Atticus H Hainsworth

Open access · goldAbstract read
In one paragraph

Article in Alzheimer's & dementia (New York, N. Y.), 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 11 papers.

0numbers the graph read from it
0cells of the map it votes in
11citing papers in PubMed
2.8field-weighted citation impact, top 9% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

11 citing papers in PubMed, 25 citations in OpenAlex.

  1. Article
  2. Review
  3. Article
  4. Article
  5. Review
  6. Article
  7. Histopathological Analysis of Cerebrovascular Lesions Associated With Aging.Journal of neuropathology and experimental neurology · 2022
    Observational
  8. Review
  9. Article
  10. Significance of cerebral amyloid angiopathy and other co-morbidities in Lewy body diseases.Journal of neural transmission (Vienna, Austria : 1996) · 2021
    Article
  11. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 6 institutions in 1 country.

Vafa AlakbarzadeSt George's University Hospitals London UK.
Jonathan Mr FrenchKing's College London London UK.
David R HowlettKing's College London London UK.
Johannes AttemsNewcastle University, Newcastle upon Tyne Newcastle UK.
Paul T FrancisKing's College London London UK.
Sarah StrattonSt George's University of London London UK.
Camilla N ClarkSt George's University Hospitals London UK.
Anthony C PereiraSt George's University Hospitals London UK.
Atticus H HainsworthSt George's University Hospitals London UK.
St George's Hospital · GBKing's College London · GBBristol Royal Infirmary · GBNewcastle University · GBSt George’s University Hospitals NHS Foundation Trust · GBSt George's, University of London · GB

Funding

Medical Research Council G0400074
6 · The paper itself

Abstract

introductionRadiolabeled ligands for fibrillar amyloid beta (Aβ) peptides are used in positron emission tomography (PET) for dementia diagnosis. Current ligands do not discriminate parenchymal amyloid plaques from cerebral amyloid angiopathy (CAA).

methodsWe undertook neuropathological examination of 65 older people (81.6 ± 7.96 (mean ± SD) years, 27F/38M): 15 with neuropathological diagnosis of AD, 25 with neuropathological diagnosis of other neurodegenerative dementias (Lewy body dementia and Parkinson disease dementia), and 25 without significant neurodegenerative pathology.

resultsWe observed CAA in non-Alzheimer's dementia (non-AD dementia) and control brains, of comparable extent to those with neuropathologically confirmed AD. Aβ-positive vessel density did not differ significantly between non-AD dementia and control groups. Across all subjects there was a highly significant correlation between vessel Aβ40 density and vessel Aβ42 density (Spearman rho = 0.855,

conclusionOur data indicate that CAA can be abundant in non-AD brains and raise a cautionary note regarding interpretation of amyloid PET imaging.

Indexed as

Alzheimer's diseaseamyloid PETcerebral amyloid angiopathy

Identifiers

PMID33644295
PMCPMC7885797
OpenAlexW3129836213

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.